92results about How to "Treatment stable" patented technology

The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disordrs or conditions using albumin fusion proteins of the invention.

The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disordrs or conditions using albumin fusion proteins of the invention.

The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.

Disclosed is a biological desulfurization apparatus including a reaction tower 1 into which biogas generated by anaerobic fermentation of organic waste is to be introduced, a carrier-packed layer 2a, 2b arranged in the reaction tower and provided with a carrier to which microorganisms have adhered, an air feeding pipe 3 that mixes air into a lower part of the reaction tower, and a sprinkling mechanism 7 that sprinkles water on an upper part of the reaction tower, wherein the carrier-packed layer is arranged in two or more stages.

A solid-state VC sodium injection for treating the diseases caused by VC difficiency is prepared from VC sodium, VC and the pharmacologically acceptable additives.

A process recipe is controlled by processing reflection interference light on the surface of a wafer with a signal and etching is carried out by suppressing an increase in the surface roughness of the wafer during etching. That is, a dry etching method for use in a dry etching system comprising means of treating a sample by generating plasma in a vacuum process chamber and monitor means of monitoring the reflection interference light of the sample to be treated, the method comprising the step of detecting the spectrum of reflection interference light on the surface of the sample to be treated, the step of obtaining a residual from curve fit between a theoretical value estimated from the film reflection model of the surface of the wafer and the spectrum of reflection interference light, and the step of judging whether the residual from the curve fit falls within a predetermined value.

The invention discloses a medicine for treating kidney stone and gall-stone, according to a calculus formation pathology and a pharmacological experiment formula, the medicine of the invention is prepared by arbutin, desmodium, lichee nucleus, longan nucleus, common fenugreek seed, gecko, pig iron cinder, gynostemma pentaphylla, plantago, Orthosiphon Stamineus, Caulis aristolochiae manshuriensis, bletilla rhizome, magnolia cortex and sweetleaf tea. The materials are natural-green, safe and reliable. A traditional Chinese medicine toxin expelling therapy is used. The medicine is capable of releasing spasm, relieving pain, smoothing skin, sterilizing, softening hardness and dissipating binds, soothing liver and resolving depression, clearing heat and dispersing stagnate, rectifying qi, disinhibiting urine and freeing strangury and benifiting openheartedness, the medicine can directly act on nidus, an organic matter is subjected to releasing, dissolving and biological enzymatic hydrolysis, can comprehensively permeated in a core of the calculus, the calculus can be cracked, melted and dissolved layer by layer from outer part to inner part, and the waste liquid is excreted through human excretion tissue, and the damaged cells can be activated, the gland can be balanced, the organ vitality can be enhanced, the acid-base value of blood can be balanced, the calculus recurrence can be prevented, and the simultaneous treatment of principal and subordinate symptoms effect can be acted.

The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.